Eyenovia Inc (EYEN)
0.4903
-0.04
(-7.40%)
USD |
NASDAQ |
Oct 31, 16:00
0.494
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Cash from Operations (Quarterly): -8.174M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -8.174M |
| March 31, 2024 | -9.892M |
| December 31, 2023 | -6.322M |
| September 30, 2023 | -5.841M |
| June 30, 2023 | -4.715M |
| March 31, 2023 | -6.959M |
| December 31, 2022 | -5.405M |
| September 30, 2022 | -6.817M |
| June 30, 2022 | -4.699M |
| March 31, 2022 | -8.184M |
| December 31, 2021 | -5.877M |
| September 30, 2021 | -5.095M |
| June 30, 2021 | -5.329M |
| March 31, 2021 | -4.574M |
| December 31, 2020 | 5.469M |
| Date | Value |
|---|---|
| September 30, 2020 | -1.937M |
| June 30, 2020 | -3.998M |
| March 31, 2020 | -5.918M |
| December 31, 2019 | -4.020M |
| September 30, 2019 | -3.859M |
| June 30, 2019 | -5.144M |
| March 31, 2019 | -5.897M |
| December 31, 2018 | -4.106M |
| September 30, 2018 | -3.574M |
| June 30, 2018 | -3.040M |
| March 31, 2018 | -2.391M |
| December 31, 2017 | -1.993M |
| September 30, 2017 | -0.8247M |
| June 30, 2017 | -1.044M |
| March 31, 2017 | -0.8689M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.892M
Minimum
Mar 2024
5.469M
Maximum
Dec 2020
-5.173M
Average
-5.405M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
| Reviva Pharmaceuticals Holdings Inc | -8.476M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -6.472M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0457M |
| Cash from Financing (Quarterly) | 2.545M |
| Free Cash Flow | -32.24M |
| Free Cash Flow Per Share (Quarterly) | -0.1547 |
| Free Cash Flow to Equity (Quarterly) | -7.384M |
| Free Cash Flow Yield | -139.7% |